Skip to content

Treating Suicidality Remotely: a randomized controlled trial of brief cognitive behavioral therapy for suicide prevention via chat or phone

Treating Suicidality Remotely: a randomized controlled trial of brief cognitive behavioral therapy for suicide prevention via chat or phone - Treating Suicidality Remotely (TREASURE)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56714
Enrollment
364
Registered
2024-03-22
Start date
2024-05-07
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

zelfdoding suicidality suicide

Interventions

Brief cognitive behavioral therapy for suicide prevention, consisting of 12 sessions with a therapist via chat or phone. 113 Suicide Prevention's online self-help course, consisting of 6 lessons eac

Sponsors

113 Zelfmoordpreventie
Lead Sponsor

Eligibility

Age
16 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 16 years or older - living in The Netherlands - Any type of STBs in the past 4 weeks, as indicated by a score >=1 to the C-SSRS

Exclusion criteria

Exclusion criteria: - Insufficient mastery of the Dutch language - Previously engaged in CBT-SP or 113's online self-help course - Currently seeing a mental health professional at least once every 3 weeks, other then a general practitioner or general practice based nurse practitioner (*POH-GGZ*) - Not able to engage in online therapy, for instance because of severe thought disorders, based on the clinical impression of the therapist or research assistant and a supervisor

Design outcomes

Primary

MeasureTime frame
Number of suicide attempts, including fatal attempts (measured with the interview version of the C-SSRS)

Secondary

MeasureTime frame
Suicidal thoughts (measured with the interview version of the C-SSRS), adverse effects (measured with the NEQ), treatment satisfaction (measured with the CSQ-8), mental health problems (measured with the MINI), quality of life (measured with the MHQoL) and healthcare utilization (measured with the TiC-P mini).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)